Sobi® (STO: SOBI), today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application... Feb 26, 2025, 09:07 ETSway Medical, Inc. Announces FDA 510(k) Clearance of its Comprehensive Concussion Management System ...
International Conference on Culture, Languages and Linguistics International Conference on Health, Science and Technology Articles / News / Press releases Stem cell in disease and treatment Efficiency Of Proteolytic Enzymes In Treating Lumbar Spine Osteoarthritis (Low Back Pain) Patients And Its Effects On...
Press Announcements - FDA releases groundbreaking food safety rules for produce farms and imported food to modernize and strengthen food safety systemThe U.S. Food and Drug Administration today took major steps to prevent foodborne illness by finalizing rules implementing the bipartisan Food Safety ...
Usually, the FDA puts out a release and/or communicates to the company, which in turn will issue a press release. Create a Watchlist FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.Click to Get Started...
FDA Releases Draft Guidance on Confirmatory Trials for Accelerated Approvals January 9, 2025 By Jordyn Sava Fact checked by Jason M. Broderick News ArticleA draft guidance from the FDA outlines criteria for confirmatory trials in accelerated approvals, emphasizing timely initiation, sponsor engagement,...
Press Releases Intangibles CIM BioMed Audio Podcast Library @LPBI Group Medical School Education: Use of LPBI Group’s Contents ChatGPT + Wolfram PlugIn Medicine with GPT-4 & ChatGPT Grok, DeepSeek & Expert Models in HealthcareLeaders in Pharmaceutical Business Intelligence Group, LLC, Doing Busi...
FDA Supports Innovation in Animal Biotechnology, Veterinary Products, Food for Animals Through New Comprehensive Agenda. News release. US Food and Drug Administration. September 15, 2023. Accessed September 18, 2023.https://www.fda.gov/news-events/press-announcements/fda-supports-innovation-animal-biot...
This press release contains “forward-looking” statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to: Day One’s plans to develop cancer therapies, expectations from current clinical trials,...
TherapeuticsMD, Inc. (NASDAQ:TXMD) (“TXMD” or the “Company”), an innovative, leading women’s healthcare company, today announced that the FDA determined that it could not approve revisions to certain manufacturing testing limits...
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-drug-application-initiated-with-us-fda-for-tar-200-the-first-and-only-intravesical-drug-releasing-system-for-patients-with-bcg-unresponsive-high-risk-non-muscle-invasive-bladder-cancer-302351745...